LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients

Clinical trial NCT05410951 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05410951
Sponsor: European Institute of Oncology
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Lobular Breast Carcinoma Lobular in Situ Breast Carcinoma BRCA1 Mutation BRCA2 Mutation

Start date: 2022-05-16
Primary completion: 2025-12-31
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.